Marcus Mall

118PUBLICATIONS
421CO-AUTHORS
Infant and child healthClinimetricsRespiratory diseasesHaematological tumoursAerodynamics (excl. hypersonic aerodynamics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (118)

|Oct 27, 2026
Long-term safety and efficacy of lumacaftor/ivacaftor in children aged ≥12 months of age with cystic fibrosis: a 96-week open-label study.

|Oct 26, 2026
Conditionally Reprogrammed Patient-Derived Nasal Epithelial Cell Cultures for In Vitro Diagnostics and Pharmacological Profiling in Primary Ciliary Dyskinesia.

|Oct 07, 2026
The dipeptidyl peptidase 1 inhibition landscape in bronchiectasis and its future direction.

|Oct 01, 2026
Phase III AIRTIVITY study design: verducatib (BI 1291583) in people with bronchiectasis.

|Sep 24, 2026
Elexacaftor/tezacaftor/ivacaftor improves CFTR function to near-normal levels in children with cystic fibrosis.

|Sep 15, 2026
Post-exposure prophylaxis with a monoclonal antibody cocktail after Bundibugyo ebolavirus exposure in adults and children.

Pageof 20

Frequent Collaborators

30 joint publications

Mirjam Stahl

22 joint publications

Simon Y Graeber

18 joint publications

Mark O Wielpütz

14 joint publications

Julia Duerr